Project Grant HT94252510425
Award Date
6/1/25
Completion Date
5/31/28
Dollars Obligated
$783K
Federal Agency
Defense Health Agency
Awardee
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. (UYLKBRENAPG5)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Westlake, MD 20817, USA
Similar Awards
This federal Project Grant award, valued at $1,030,660.00, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The primary awardee, The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., will conduct scientific investigations spanning basic, applied, and...
The federal Project Grant award in the amount of $2,402,721.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports the development of a patient monitoring and decision-support platform for precision health initiatives. The award was made to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., a non-profit organization that specializes in providing medical research, education, and...
The Defense Health Agency awarded a $168,200 Project Grant to Health Research, Inc. Roswell Park Division under the Military Medical Research and Development program (CFDA 12.420) to investigate alternative polyadenylation as a mediator of therapeutic resistance in lung cancer. The two-year award beginning July 1, 2021 will support research into innovative medical solutions for lung cancer treatment through the study of alternative polyadenylation, a novel area of investigation that could help...
This federal Project Grant award of $1,460,695.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund the "DEVELOPMENT AND VALIDATION OF AN EPIGENOMIC LANDSCAPE AND NOVEL IMMUNOTHERAPY IN PROSTATE CANCER DISPARITIES" over the period of September 1, 2025 to August 31, 2028. The award recipient is The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc., a non-profit organization...
This $159,900 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports preclinical research on brain metastases in lung cancer. The award will fund studies at the University of Illinois to develop and evaluate novel drug efficacy and resistance models for advancing the treatment of brain metastases, a significant challenge in lung cancer management. Spanning one year from August 2024 to August...
This $762,992 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by the University of Texas MD Anderson Cancer Center to map and predict therapy resistance in small cell lung cancer (SCLC) using liquid biopsies. The 3-year award, effective July 1, 2024, will enable MD Anderson to conduct personalized analyses to better understand how SCLC tumors evolve and become resistant to treatment. This work aims to...
The Department of the Army Medical Command awarded a $157,500 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from June 1, 2021 to May 31, 2022 to restore functional ARF tumor suppression in non-small cell lung carcinoma through the use of peptide mimics. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
This $819,841 federal Project Grant awarded by the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), supports Duke University's research to pharmacologically activate a newly discovered KEAP1-ATF4-CHOP axis in order to select against targeted therapy resistance in non-small cell lung cancer (NSCLC). The research project aims to develop new treatments that can overcome resistance to existing targeted therapies for NSCLC. Duke University, through its...
The Defense Health Agency awarded a $159,892 Project Grant to the University of Illinois under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant supports research into "Metabolic Vulnerabilities Associated to G12C Inhibitor Resistance" from January 1, 2022 through December 31, 2023. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions. This award will...
The Defense Health Agency awarded Massachusetts General Hospital a $582,732 project grant under the Military Medical Research and Development program to conduct research titled "Metabolic Targets to Overcome Chemoradiation Resistance in Genotype-Defined Non-Small Cell Lung Carcinoma." The CFDA number for the program is 12.420. Through this award spanning July 1, 2023 to June 30, 2025, MGH will investigate medical solutions for lung cancer treatment in military service members and the...